[go: up one dir, main page]

MX2017000764A - Formulacion acuosa que comprende paracetamol e ibuprofeno. - Google Patents

Formulacion acuosa que comprende paracetamol e ibuprofeno.

Info

Publication number
MX2017000764A
MX2017000764A MX2017000764A MX2017000764A MX2017000764A MX 2017000764 A MX2017000764 A MX 2017000764A MX 2017000764 A MX2017000764 A MX 2017000764A MX 2017000764 A MX2017000764 A MX 2017000764A MX 2017000764 A MX2017000764 A MX 2017000764A
Authority
MX
Mexico
Prior art keywords
paracetamol
ibuprofen
aqueous formulation
relates
present
Prior art date
Application number
MX2017000764A
Other languages
English (en)
Other versions
MX381776B (es
Inventor
Jacobsen Thomas
Original Assignee
Everbright Pharmaceuticals S A R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Everbright Pharmaceuticals S A R L filed Critical Everbright Pharmaceuticals S A R L
Publication of MX2017000764A publication Critical patent/MX2017000764A/es
Publication of MX381776B publication Critical patent/MX381776B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/10—Bag-type containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2093—Containers having several compartments for products to be mixed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/1407—Infusion of two or more substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/19—Syringes having more than one chamber, e.g. including a manifold coupling two parallelly aligned syringes through separate channels to a common discharge assembly
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)

Abstract

La presente invención se refiere a una composición acuosa de ibuprofeno y paracetamol de pH 6.3-7.3 y a su uso; la presente invención se refiere a un método para preparar un producto de combinación de ibuprofeno y paracetamol; también se refiere a las composiciones para usarse como un medicamento, especialmente para el tratamiento de dolor y/o inflamación; especialmente para la administración de la composición mediante inyección intravenosa.
MX2017000764A 2014-07-18 2015-07-17 Formulacion acuosa que comprende paracetamol e ibuprofeno. MX381776B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/EP2014/065544 WO2016008546A1 (en) 2014-07-18 2014-07-18 Aqueous formulation comprising paracetamol and ibuprofen
PCT/EP2015/066466 WO2016009067A1 (en) 2014-07-18 2015-07-17 Aqueous formulation comprising paracetamol and ibuprofen

Publications (2)

Publication Number Publication Date
MX2017000764A true MX2017000764A (es) 2017-08-18
MX381776B MX381776B (es) 2025-03-13

Family

ID=51211244

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017000764A MX381776B (es) 2014-07-18 2015-07-17 Formulacion acuosa que comprende paracetamol e ibuprofeno.

Country Status (26)

Country Link
US (5) US11219609B2 (es)
EP (2) EP3169307B1 (es)
JP (2) JP6745798B2 (es)
CN (2) CN113018258A (es)
AR (1) AR100365A1 (es)
AU (1) AU2015289035B2 (es)
BR (1) BR112017001093B1 (es)
CA (1) CA2955557C (es)
CY (1) CY1122899T1 (es)
DK (1) DK3169307T3 (es)
EA (1) EA036212B1 (es)
ES (2) ES2791349T3 (es)
HR (1) HRP20200704T1 (es)
HU (1) HUE048881T2 (es)
IL (1) IL250112B2 (es)
LT (1) LT3169307T (es)
MX (1) MX381776B (es)
MY (1) MY192813A (es)
NZ (1) NZ728796A (es)
PL (2) PL3656377T3 (es)
PT (1) PT3169307T (es)
RS (1) RS60289B1 (es)
SG (1) SG11201700421RA (es)
SI (1) SI3169307T1 (es)
TN (1) TN2017000011A1 (es)
WO (2) WO2016008546A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016008546A1 (en) 2014-07-18 2016-01-21 Everbright Pharmaceuticals S.A.R.L. Aqueous formulation comprising paracetamol and ibuprofen
JP7386080B2 (ja) * 2016-08-02 2023-11-24 アンバー アイピー リミテッド 安定なイブプロフェン注射製剤用組成物
DE102017202510A1 (de) 2017-02-16 2018-08-16 Eurozyto Gmbh Behältnis zur Bereitstellung patientenspezifischer Arzneimittel
WO2018192664A1 (en) * 2017-04-20 2018-10-25 Hyloris Developments Sa METHOD FOR PREPARING A COMPOSITION WITH A LOW DISSOLVED OXYGEN CONTENT, COMPRISING ACETAMINOPHEN, AND OPTIONALLY ONE OR MORE NSAIDs, AND A COMPOSITION OBTAINED THEREOF
WO2022178018A1 (en) * 2021-02-19 2022-08-25 Nevakar Injectables Inc. Liquid unit dosage forms for treatment of pain
AU2022266610A1 (en) * 2021-04-28 2023-11-02 Glaxosmithkline Consumer Healthcare Holdings (Us) Llc Ionic liquid salts of active pharmaceutical ingredients
CN114062554B (zh) * 2021-11-20 2023-07-21 山东百诺医药股份有限公司 一种同时测定对乙酰氨基酚布洛芬有关物质的分析方法
GR1010769B (el) * 2023-07-27 2024-09-18 Ιουλια Κλεωνος Τσετη Υδατικο διαλυμα ιβουπροφαινης για χρηση σε ενδοφλεβια χορηγηση
GR1010809B (el) * 2023-09-13 2024-10-25 Ιουλια Τσετη Υδατικο διαλυμα ιβουπροφαινης παρακεταμολης για χρηση σε ενδοφλεβια χορηγηση
AU2024281739A1 (en) 2023-06-02 2025-11-27 Ioulia Tseti Pharmaceutical composition comprising ibuprofen

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2809619B1 (fr) * 2000-06-06 2004-09-24 Pharmatop Nouvelles formulations aqueuses de principes actifs sensibles a l'oxydation et leur procede d'obtention
US20060100578A1 (en) * 2004-09-13 2006-05-11 Tandem Medical, Inc. Medication delivery apparatus and methods for intravenous infusions
AU2008345456A1 (en) 2008-01-03 2009-07-09 Wockhardt Research Centre Oral pharmaceutical suspension comprising paracetamol and ibuprofen
US20110166234A1 (en) 2008-10-14 2011-07-07 Atkinson Hartley Campbell Medicinal product and treatment
EP2243477A1 (de) 2009-04-22 2010-10-27 Fresenius Kabi Deutschland GmbH Paracetamol zur parenteralen Verabreichung
US8404748B2 (en) * 2009-08-13 2013-03-26 Neogen N.V. Storage-stable formulation of paracetamol in aqueous solution
PT2389923E (pt) * 2010-05-19 2013-03-28 Uni Pharma Kleon Tsetis Pharmaceutical Lab S A Formulação injectável estável de paracetamol pronta a usar
CN107519159A (zh) * 2010-11-04 2017-12-29 阿福特药物有限公司 复方组合物
BE1020614A5 (nl) 2012-01-27 2014-01-07 Hubert De Backer Nv Injectiespuit.
US9072661B2 (en) * 2012-03-16 2015-07-07 Cumberland Pharmaceuticals Inc. Injectable ibuprofen formulation
KR101777587B1 (ko) * 2012-03-16 2017-09-13 큠버랜드 파마슈티컬즈 인코포레이티드 주사가능한 이부프로펜 제제
WO2016008546A1 (en) 2014-07-18 2016-01-21 Everbright Pharmaceuticals S.A.R.L. Aqueous formulation comprising paracetamol and ibuprofen
WO2018192664A1 (en) 2017-04-20 2018-10-25 Hyloris Developments Sa METHOD FOR PREPARING A COMPOSITION WITH A LOW DISSOLVED OXYGEN CONTENT, COMPRISING ACETAMINOPHEN, AND OPTIONALLY ONE OR MORE NSAIDs, AND A COMPOSITION OBTAINED THEREOF

Also Published As

Publication number Publication date
HUE048881T2 (hu) 2020-08-28
JP2017522382A (ja) 2017-08-10
CA2955557C (en) 2021-06-22
EP3656377B1 (en) 2025-02-12
EA201790223A1 (ru) 2017-05-31
RS60289B1 (sr) 2020-07-31
ES3013411T3 (en) 2025-04-11
CN106794163B (zh) 2021-03-26
US11213498B2 (en) 2022-01-04
NZ728796A (en) 2023-05-26
AU2015289035B2 (en) 2020-03-26
JP6745798B2 (ja) 2020-08-26
EP3169307A1 (en) 2017-05-24
US20190343785A1 (en) 2019-11-14
BR112017001093A2 (pt) 2017-11-14
JP6892494B2 (ja) 2021-06-23
TN2017000011A1 (en) 2018-07-04
AR100365A1 (es) 2016-09-28
WO2016009067A1 (en) 2016-01-21
US11219609B2 (en) 2022-01-11
MY192813A (en) 2022-09-09
US20230181502A1 (en) 2023-06-15
EA036212B1 (ru) 2020-10-14
MX381776B (es) 2025-03-13
IL250112B (en) 2022-10-01
EP3656377C0 (en) 2025-02-12
US20250064764A1 (en) 2025-02-27
EP3169307B1 (en) 2020-02-19
IL250112B2 (en) 2023-02-01
US12083087B2 (en) 2024-09-10
DK3169307T3 (da) 2020-05-11
US20170209398A1 (en) 2017-07-27
PT3169307T (pt) 2020-05-18
US20220031645A1 (en) 2022-02-03
CY1122899T1 (el) 2021-05-05
HRP20200704T1 (hr) 2020-07-24
EP3656377A1 (en) 2020-05-27
US11389416B2 (en) 2022-07-19
CN106794163A (zh) 2017-05-31
ES2791349T3 (es) 2020-11-04
AU2015289035A1 (en) 2017-02-23
SG11201700421RA (en) 2017-02-27
BR112017001093B1 (pt) 2023-01-31
CN113018258A (zh) 2021-06-25
JP2020059740A (ja) 2020-04-16
SI3169307T1 (sl) 2020-07-31
CA2955557A1 (en) 2016-01-21
PL3169307T3 (pl) 2020-09-21
WO2016008546A1 (en) 2016-01-21
PL3656377T3 (pl) 2025-05-26
LT3169307T (lt) 2020-07-10
IL250112A0 (en) 2017-03-30

Similar Documents

Publication Publication Date Title
MX2017000764A (es) Formulacion acuosa que comprende paracetamol e ibuprofeno.
SV2017005461A (es) Benzamidas sustituidas con 1,3-tiazol-2-ilo
MY196909A (en) Boronic acid derivatives and therapeutic uses thereof
UY36665A (es) Derivados de ciclohexano sustituidos con amidas
EA201692301A1 (ru) Производные бороновой кислоты и их терапевтическое применение
MX2016015093A (es) Derivados de acido boronico y sus usos terapeuticos.
ECSP17007538A (es) 2-(morfolin-4-il)-1,7-naftiridinas
AR090491A1 (es) Tratamiento de la esclerosis multiple con una combinacion de laquinimod y fumarato de dimetilo
BR112016011065A8 (pt) composto cristalino, composição farmacêutica, forma de dosagem, método para tratar anemia
DOP2016000253A (es) Nuevos compuestos
CL2016001918A1 (es) Heteroaril amidas como inhibidores de agregación de proteína
MX2017006113A (es) Nuevos profarmacos polimericos de la hormona del crecimiento humana (hgh).
EA201691918A1 (ru) Фармацевтические составы ингибитора киназ семейства raf, способы их получения и способы их применения
BR112016022394A2 (pt) Composição farmaceuticamente aceitável, composição na forma de uma solução injetável farmaceuticamente aceitável, uso da composição, e, método para a preparação da composição injetável farmaceuticamente aceitável
CL2019001746A1 (es) Amidas aromáticas de ácido carboxílico
DOP2016000251A (es) Inhibidores de las vías de señalización de wnt
CL2018002848A1 (es) Formulaciones liquidas de fosfoplatino
CR20160369A (es) Composiciones para uso en el tratamiento de afecciones alérgicas
BR112019017314A2 (pt) composições farmacêuticas para terapia de combinação
RU2012129115A (ru) Способ лечения острых послеродовых эндометритов у коров
CO7170180A2 (es) Composición farmacéutica inyectable de dexketoprofeno y tramadol
CL2015003780A1 (es) Compuestos derivados pirimido-isoquinolin-quinonas, sus sales, isomeros, tautomeros farmacéuticas aceptables; composiciones farmáceuticas; procedimiento de preparación; y su uso en el tratamiento de enfermedades bacterianas y bacterianas multirresistentes.
AR130700A2 (es) Composiciones de grapiprant y métodos para su utilización
BR112016029761A8 (pt) composições compreendendo um derivado de ácido quinolona carboxílico e agentes efervescentes, uso das mesmas e forma cristalina do referido derivado
BR112015030751A2 (pt) formas polimórficas de icotinib e usos das mesmas